Merck & Co.

American multinational pharmaceutical company

MRK NYSE ISIN US58933Y1055 SEC CIK 310158 LEI 4YV9Y5M8S0BRK1RP0397
Follow Merck & Co. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $18.1B +4.7% vs same quarter last year
Net income $5.1B −12.4% vs same quarter last year
EPS, diluted $2.04 −12.1% vs same quarter last year
Operating cash flow $6.6B −16.2% vs same quarter last year
Revenue by quarter
$15.6B
$15.5B
$15.8B
$17.3B
$16.4B
$16.3B
$16.6B
$18.1B
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
$0$20B$40B$60B$80BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$65B$18.3B
FY24$64.2B$17.1B
FY23$60.1B$365M
FY22$59.3B$14.5B
FY21$48.7B$12.3B
FY20$41.5B$7.1B
FY19$39.1B$9.8B
FY18$42.3B$6.2B
FY17$40.1B$2.4B
FY16$39.8B$3.9B
FY15$39.5B$4.4B
FY14$42.2B$11.9B
FY13$44B$4.4B
FY12$47.3B$6.2B
FY11$48B$6.3B
MarginsShare of revenue
  • Gross margin
  • Net margin
0%20%40%60%80%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginNet margin
FY2574.8%28.1%
FY2476.3%26.7%
FY2373.2%0.6%
FY2270.6%24.5%
FY2172%25.3%
FY2067.2%17%
FY1969.3%25.2%
FY1868.1%14.7%
FY1767.8%6%
FY1664.8%9.8%
FY1562.2%11.2%
FY1460.3%28.2%
FY1361.5%10%
FY1265.2%13%
FY1164.9%13.1%
Free cash flowOperating cash flow minus capital expenditure
$0$5B$10B$15B$20BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$12.4B
FY24$18.1B
FY23$9.1B
FY22$14.7B
FY21$8.7B
FY20$5.8B
FY19$10.1B
FY18$8.3B
FY17$4.6B
FY16$8.8B
FY15$11.3B
FY14$6.7B
FY13$10.1B
FY12$8.1B
FY11$10.7B
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$5B$10B$15BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$8.2B$5.1B
FY24$7.8B$1.3B
FY23$7.4B$1.3B
FY22$7B$0
FY21$6.6B$840M
FY20$6.2B$1.3B
FY19$5.7B$4.8B
FY18$5.2B$9.1B
FY17$5.2B$4B
FY16$5.1B$3.4B
FY15$5.1B$4.2B
FY14$5.2B$7.7B
FY13$5.2B$6.5B
FY12$5.1B$2.6B
FY11$4.7B$1.9B
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Merck & Co.
  • Healthcare median
−100%−50%0%50%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearMerck & Co.Healthcare median
FY2528.1%−30.6%
FY2426.7%−47%
FY230.6%−58%
FY2224.5%−80.4%
FY2125.3%−71.9%
FY2017%−62.2%
FY1925.2%−46.3%
FY1814.7%−49.6%
FY176%−45.9%
FY169.8%−36%
FY1511.2%−38.4%
FY1428.2%−35.5%
FY1310%−37.1%
FY1213%−29.1%
FY1113.1%−27.9%